FDA grants marketing approval for US Army’s malaria treatment

pharmafile | May 28, 2020 | News story | Business Services Malaria drug, US, US army, US., malaria 

The FDA has granted marketing approval for the US Army Medical Research and Development Command’s (USAMRDC) Artesunate for injection, which is a treatment for severe malaria.

The drug was developed by the Walter Reed Army Institute of Research (WRAIR) and the US Army Medical Materiel Development Activity, a subordinate of the USAMRDC. The New Drug Application was submitted with Amivas USA, and was approved following review.

Army Major Victor Zottig, malaria product manager for USAMMDA’s Warfighter Protection and Acute Care Project Management Office, said: “The FDA approval of Artesunate for Injection is another notable achievement for the U.S. Army in its long history of developing therapies for combating malaria. With a lack of alternate FDA-approved therapies to treat life-threatening severe malaria, Artesunate for Injection fills a critical gap for the military and U.S. population.”

The approval of Aresunate by injection will help fill the US’s need for an effective treatment for people suffering with severe malaria. Beforehand, the Army’s supply of the drug had only been available to Warfighters deployed overseas.

The initial development of the treatment in the US was led by the WRAIR who isolated the compound artemisinin from its natural source Artemisia annua, which is found on the banks of the Potomac River. Malaria is one of the top infectious disease threats to US military personnel stationed overseas.

Conor Kavanagh

Related Content

Expansion for first FDA-approved video game for ADHD treatment

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the …

New warning added to J&J vaccine in US

The FDA has made the decision to add a warning to the fact sheet for …


CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab

Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use …

Latest content